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DGFB is a growth factor which is vital for the completion of normal prenatal development. In this study, we report the
henotypic analysis of placentas from mouse conceptuses that lack a functional PDGFB or PDGFRb gene. Placentas of both
ypes of mutant exhibit changes in the labyrinthine layer, including dilated embryonic blood vessels and reduced numbers
f both pericytes and trophoblasts. These changes are seen from embryonic day (E) 13.5, which coincides with the
pregulation of PDGFB mRNA levels in normal placentas. By E17, modifications in shape, size, and number of the fetal
lood vessels in the mutant placentas cause an abnormal ratio of the surface areas between the fetal and the maternal blood
essels in the labyrinthine layer. Our data suggest that PDGFB acts locally to contribute to the development of the
abyrinthine layer of the fetal placenta and the formation of a proper nutrient–waste exchange system during fetal
evelopment. We point out that the roles of PDGFB/Rb signaling in the placenta may be analogous to those in the
eveloping kidney, by controlling pericytes in the labyrinthine layer and mesangial cells in the kidney.
Key Words: trophoblasts; labyrinthine; morphology; blood vessels; pericytes.t
dINTRODUCTION
Platelet-derived growth factor (PDGF) is a potent mitogenic
agent for connective tissue cells such as fibroblasts and
smooth muscle cells and for glial cells such as oligodendrocyte
progenitors (Heldin and Westermark, 1990; Raines et al., 1990;
aines and Ross, 1993; Calver et al., 1998). PDGF is synthe-
ized by a variety of cell types, including vascular endothelial
ells, monocytes/macrophages, placental cytotrophoblasts,
nd certain neurons. PDGF is a dimeric molecule composed of
isulfide-bonded A and/or B polypeptide chains, PDGFA and
DGFB, which are the products of two distinct genes (Heldin
nd Westermark, 1989). PDGF dimers signal via homo- or
eterodimers of two receptor types. The PDGF a-receptor
(PDGFRa) interacts with both the A and the B chain of PDGF,
hereas the PDGF b-receptor (PDGFRb) preferentially binds
he B chain (Heldin and Westermark, 1990). Both receptor
1 To whom correspondence should be addressed. Fax: 146-18-
n4712683. E-mail: Rolf.Ohlsson@DevBiol.uu.se.
124ypes elicit potent mitogenic signals, although only PDGFRb
mediates chemotaxis and actin reorganization in certain cell
types, such as human fibroblasts and porcine aortic endothe-
lial cells (Hammacher et al., 1989).
In adults, most of the functions of PDGF relate to
different responses to injury, such as inflammation, vascu-
lar injury, and wound healing (Heldin and Westermark,
1990; Ross et al., 1986; Khachigian et al., 1996). Increased
expression of PDGF and PDGF receptors is seen in a
number of pathological conditions, including atherosclero-
sis, connective tissue overgrowth in conjunction with
chronic inflammatory processes, fibrosis, and tumor stroma
formation (Raines and Ross, 1993). The successive activa-
tion of the PDGFB and PDGFRb genes during the genesis of
choriocarcinoma may reflect the establishment of a persis-
tent autocrine loop (Holmgren et al., 1994). The most
striking illustration of the importance of PDGFB and
PDGFRb function can be found, however, during prenatal
evelopment. PDGFB- or PDGFRb-deficient mice die peri-
atally and exhibit specific developmental abnormalities
0012-1606/99
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125PDGF and Placental Development(Leve´en et al., 1994; Soriano, 1994). These include mal-
ormed kidney glomerular tufts and the formation of mi-
roaneurysms due to loss of mesangial cells and microvas-
ular pericytes (Lindahl et al., 1997a, 1998). Most embryos
evelop fatal vascular leakage and rupture of microvessels
ust prior to birth. The hematological status of such mice
ncludes erythroblastosis, macrocytic anemia, and throm-
ocytopenia. The fact that similar phenotypes are observed
ith both mutants suggests failure of PDGFB interaction
ith PDGFRb, rather than with PDGFRa.
The communication between the fetus and the mother
ccurs via the placenta in all eutherian mammals. In the
ouse placenta, contact between the fetal and the maternal
irculatory systems takes place in the labyrinthine layer, in
hich the two intermingled networks of vessels—fetal
apillaries and maternal lacunas—form a large contact
urface for nutrient exchange and excretion. The labyrin-
hine layer is functionally analogous to the region of the
uman placenta containing the chorionic villi, which carry
he fetal capillaries, and the intervillus spaces, which con-
ain the maternal blood. We show here that PDGFB- and
DGFRb-deficient mouse placentas have a specific defect
n the labyrinthine layer, characterized by reduced numbers
f pericytes and labyrinth trophoblasts, dilated fetal blood
essels, and a reduced contact surface for maternal blood.
ased on the phenotypic similarities between PDGFB- and
DGFRb-null placentas and kidney glomeruli, we propose
hat placental pericytes and kidney mesangial cells may
ave similar functions in the morphogenesis of complex
apillary tufts involved in excretion and/or nutrient ex-
hange.
MATERIALS AND METHODS
Production of PDGFB-, PDGFA-, PDGFRb-, and PDGFRa-
mutant conceptuses. The derivation of mutant mice has already
been described (Leve´en et al., 1994; Soriano, 1994; Bostro¨m et al.,
1996; Soriano, 1997). 129SV/C57Bl/6 hybrid offspring or embryos
were genotyped by Southern blot analysis or PCR as described
(Leve´en et al., 1994; Soriano, 1994; Lindahl et al., 1997a,b).
Histological analysis. Placentas were processed for routine
histology by fixation in Bouin’s solution, or in 4% paraformalde-
hyde in PBS, followed by paraffin embedding and sectioning. Four-
to seven-micrometer sections were stained with PAS–Schiffs re-
agents and Mayer’s hematoxylin–eosin. For electron microscopy,
placentas were fixed overnight at 4°C in 3% glutaraldehyde in 0.1
M cacodylate buffer and postfixed at room temperature in 1%
osmium tetraoxide in 0.1 M cacodylate buffer. Following fixation,
the placentas were stained with 1% uranyl acetate and finally
embedded in epoxy resin. Sections were contrasted with lead
citrate before analysis in a Philips transmission electron micro-
scope.
Placental sections were stained with isolectin to visualize the
matrix surrounding the fetal blood vessels (Wood et al., 1979).
Sections were incubated in PBS containing 0.6% H2O2 for 10
in; in PBS, pH 6.8, 1% Triton X-100, 0.1 mM CaCl2, 0.1 mM
gCl2, 0.1 mM MnCl2 for 15 min at room temperature; and then
with 5 mg/ml isolectin B4 from Bandeiraea simplicifolia conju-
ated with peroxidase (Sigma) in a humid chamber for 2 h.
Copyright © 1999 by Academic Press. All righteroxidase activity was detected by conventional DAB staining
Vectastain). Staining of placenta pericytes was done using
ntibodies against a-smooth muscle actin (ASMA) or desmin as
described (Lindahl et al., 1998)
Morphometric and statistical analysis. Cell numbers within
the labyrinthine layer were counted from randomly chosen areas
measuring 0.27 3 0.21 mm. Fetal blood vessels could be distin-
guished from maternal blood lacunas by the presence of endothelial
cells and adjacent isolectin-positive matrix (see Results). The
surface areas (parametric length; 1000 units equivalent to 1 mm2) of
fetal blood vessels and maternal blood lacunas were scored from
randomly chosen areas (0.27 3 0.21 mm) in the labyrinthine layer
and analyzed using the computer program NIH Image 1.58. At least
three different specimens from each of the wild-type, PDGFB-
deficient, and PDGFRb-deficient placentas were examined in 9–16
reas (from nine different glass slides). Although measurements
ere analyzed using average and standard deviation of error, they
ere also tested using the ranking nonparametric Mann–Whitney
test. Comparisons of cell and vessel numbers and parametric
ength variations between wild-type versus PDGFB 2/2 and
PDGFRb 2/2 showed that the probabilities that the measure-
ments are part of the same populations of values were P , 0.0001
or all the statistical calculations presented in Fig. 6. The volumes
f the indicated placentas were analyzed by measuring the para-
etric surfaces of the labyrinthine and the spongiotrophoblast
ayers in every third section (each 7 mm thin) throughout each
specimen. The volumes were then calculated using the NIH Image
software.
RNA probes. The PDGFRb probe was derived from the
pSVRI clone (Yarden et al., 1986) and was a kind gift from Dr. J.
Escobedo. A 5.4-kb insert was subcloned in pBluescript KS
plasmid. RNA polymerases T7 and T3 generated sense and
antisense probes, respectively. The mouse PDGFB probe was
generated from a cDNA clone isolated from a lgt10 cDNA
ibrary of mouse fetal mRNA (Stratagene) using a human PDGFB
DNA probe. The 2.2-kb insert, starting 918 bp downstream of
he cap site and ending within exon 7, was subcloned into a
BSKS plasmid. RNA polymerases T7 and T3 were used to
enerate sense and antisense probes, respectively. The PDGFRa
template was a 234-bp segment (Mercola et al., 1990) containing
39 untranslated sequences and was a kind gift from Dr. M.
Mercola. RNA polymerases T7 and T3 were used to generate
antisense and sense probes, respectively.
Hybridization analysis. Northern blot hybridization analysis
of total cellular RNA, extracted from the dissected placentas and
juxtaposed decidua, was performed as described (Ohlsson et al.,
1989). In situ hybridization analysis was performed on 7-mm
araffin sections of paraformaldehyde- or Bouin’s-solution-fixed
lacentas using 35S-labeled antisense riboprobes as described (Ohls-
on et al., 1989). After being washed, slides were dipped into NTB2
mulsion (Kodak) and exposed for 1–2 weeks at 4°C. After devel-
pment and fixation, sections were counterstained with Mayer’s
ematoxylin and mounted. Digital images of the sections were
ollected using a ColourCoolView integrating video camera (Pho-
onic Science, UK) and a Leica DMRXE light microscope. Images
ere processed and mounted using Adobe PhotoShop software,
ersion 4.0.
RESULTS
PDGF and PDGF receptor mRNA expression. PDGFB
is temporally controlled during mouse placenta develop-
s of reproduction in any form reserved.
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126 Ohlsson et al.ment (Fig. 1) with levels increasing significantly after E12,
in agreement with previous results (Bidwell et al., 1995).
Given the minute amounts of placental tissue during early
embryonic development, the PDGFB signal in microdis-
sected placentas at embryonic day (E) 9 may reflect con-
tamination with embryonic tissue. We cannot, however,
formally rule out the existence of a biphasic pattern of
PDGFB expression with a first, more modest period of
expression ending at E10. Reprobing of these blots revealed
no detectable PDGFA expression (data not shown). To
determine in which cell types the PDGFB gene is expressed,
we performed in situ hybridization analysis: the bulk of
PDGFB mRNA is confined to the labyrinthine layer of
placentas by E17 (Fig. 2B). Closer examination showed that
the PDGFB transcripts were localized primarily to subpopu-
lations of the labyrinth trophoblasts and endothelial cells
and, to a lesser extent, in some giant trophoblasts (Fig. 2E
and data not shown). PDGFRb expression was likewise
restricted to the labyrinthine layer, but appeared more
evenly distributed than that of PDGFB. These studies do
not conclusively resolve the expression patterns at the level
of single cells, but the results are compatible with PDGFB
expression by capillary endothelium and PDGFRb expres-
sion by trophoblasts and vascular mural cells, as has been
suggested from other studies (Goustin et al., 1985;
Holmgren et al., 1991, 1992; Lindahl et al., 1997a, 1998).
There was no detectable hybridization of the PDGFB probe
to PDGFB 2/2 placentas (Fig. 2H), even though the tar-
geted mutation involved deletion of only exon 4 (Leve´en et
l., 1994). Moreover, the absence of any marked effects on
he levels of PDGFRb mRNAs in PDGFB-deficient (Fig. 2I)
r on PDGFB levels in PDGFRb-deficient (not shown)
FIG. 1. Developmental profile of PDGFB expression. Northern
blot analysis of total cellular RNA, prepared from different stages of
placental development. The ethidium bromide-stained agarose gel
is included to show that each lane contains comparable amounts
(20 mg) of input RNA. The numbers at the top depict days
postconception.lacentas argues against the existence of any autoregulatory
Copyright © 1999 by Academic Press. All rightathways involving these genes. PDGFRa expression was
seen only in the spongiotrophoblast layer (Figs. 2D and 2G)
and did not overlap with the expression of PDGFB and
PDGFRb.
PDGFB- and PDGFRb-deficient placentas display
hanges in the maternal–fetal interface. The function of
he labyrinthine layer is to provide a pivotal nutrient–waste
xchange compartment for the developing fetus. The exten-
ive coexpression of the PDGFB and PDGFRb genes in the
abyrinthine layer might be suggestive of a short-range
unction for PDGFB at this location. Electron microscopy
hows that placental maternal lacunas are lined exclusively
ith trophoblasts, in contrast to fetal blood vessels which
re lined with endothelial cells (Fig. 3A). By light micros-
opy, maternal lacunas and the fetal blood vessels were
asily discriminated by the size of the erythrocytes (small
nd uniform in maternal lacunas; large, irregularly shaped
nd occasionally nucleated in fetal vessels). Isolectin B4
tained the matrix surrounding the fetal vessels and was
herefore used for morphological studies (Fig. 3B). This
nalysis revealed that fetal vessels were dilated to a varying
egree in PDGFB 2/2 or PDGFRb 2/2 placentas, com-
ared with wild-type littermate tissue, in which the vessel
umens were narrower and uniform in diameter (Figs.
C–3F; and see overviews of HE stainings in Fig. 4). This
henotype was clearly seen by at E13.5, whereas at E12.5,
he mutant fetal vessels were marginally affected, if at all
Figs. 5A–5F).
We compared the sizes and the numbers of the fetal and
aternal blood compartments within the labyrinthine
ayer of normal and PDGFB- or Rb-mutant placentas in thin
sections of fixed placental tissue by stereological methods
(which estimates 3D parameters by 2D analyses; DeHoff
and Rhines, 1968). The surface of the endothelial and
trophoblast tissues facing the fetal and maternal blood,
respectively, was determined by examining the parametric
length (i.e., the length of the tissue lining the fetal or
maternal blood compartment) in thin sections. Similarly,
the volume of the blood compartments was assessed by
parametric area determinations, i.e., the surface of the
blood vessel in thin sections (see Materials and Methods for
further information). Figure 6A shows the size distribution
of individual blood vessels (parametric length and area are
represented by blue and red colors, respectively) within the
fetal and maternal compartments of the labyrinthine layer
of an E17 mouse placenta. An optimal ratio of the fetal/
maternal compartments would be expected to approach 1:1,
to reflect the attainment of optimal nutrient and waste
exchange rates between the fetal and the maternal blood
circulatory systems. The size and the number ratios be-
tween fetal and maternal blood vessels in the labyrinth
trophoblast layer of wild-type E17 placentas are approxi-
mately 1:1 (Fig. 6B). In PDGFB-deficient- and to a lesser
extent in PDGFRb-deficient placentas, however, the fetal
essel parametric length and area increased relative to the
aternal lacunas (Figs. 6A and 6B).
Assessment of nonendothelial labyrinthine cells, which
s of reproduction in any form reserved.
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127PDGF and Placental Developmentare dominated by the trophoblasts, showed that their num-
ber was reduced by approximately 40% (Fig. 7A). Although
this would be expected to lead to a smaller placenta, there
is no persistent difference in the volumes of the spongio-
trophoblast and labyrinthine layers (Fig. 7C), suggesting
that there is an increased volume of blood in the labyrin-
thine layer of PDGFB- or PDGFRb-deficient fetal placentas.
This conclusion is supported by the morphometric analysis.
The increased parametric area of PDGFB-deficient fetal
vessels (Fig. 6A) and the smaller number of vessel cross-
section profiles per area (Fig. 7B) show that the mutant fetal
blood vessels are grossly dilated and should therefore con-
FIG. 2. Spatial distribution of active PDGFB, PDGFRa, and PDGF
PDGFRb (C, F) mRNAs can be found only in the labyrinthine layer
only in the juxtaposed spongiotrophoblast cell layer (st). (A) A brig
in PDGFB 2/2 placenta and (I) expression of PDGFRb mRNA in a
–J.tain a larger volume of blood. s
Copyright © 1999 by Academic Press. All rightIt is noteworthy that the spongiotrophoblast layer, which
xpresses high levels of PDGFRa mRNA, does not appear to
e affected in PDGFB- or PDGFRb-deficient placentas. We
also analyzed placentas from PDGFA 2/2 (Bostro¨m et al.,
1996; Lindahl et al., 1997b) and PDGFA/B double knockout
(Hellstro¨m et al., unpublished results) embryos. PDGFA
2/2 placentas had no apparent phenotypic abnormality,
and lack of PDGFA did not appreciably add to the effect of
PDGFB deficiency (data not shown).
Loss and altered organization of pericytes in PDGFB-
and PDGFRb-deficient placentas. PDGFB deficiency
eads to blocked recruitment of pericytes to blood vessels
nes in fetal placenta. Dark-field views show that PDGFB (B, E) and
f the E17 mouse placenta. In contrast, PDGFRa (D, G) is expressed
ld view of an adjacent section. (H) Absence of PDGFB expression
FB-deficient placenta. Scale bar, 1 mm for A–D and 0.05 mm forRb ge
(lt) o
ht-fie
PDGprouting into the developing mouse brain (Lindahl et al.,
s of reproduction in any form reserved.
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Copyright © 1999 by Academic Press. All right1997a). We compared, therefore, the abundance of pericytes
in the placentas of wild-type and PDGFB 2/2 or PDGFRb
2/2 conceptuses. Antibodies against ASMA labeled cells
located between the endothelium and the isolectin-positive
matrix surrounding the embryonic vessels (Fig. 8A). These
cells had, therefore, the marker expression and distribution
expected for pericytes in the placenta. The ASMA-positive
cells were found in the labyrinthine layer but were com-
pletely absent from the spongiotrophoblast layer, further
demonstrating an association with the fetal vessels, rather
than the maternal lacunas. Quantification of the density of
ASMA-positive profiles (a profile being a continuous area of
staining irrespective of size, representing part of a single
cell or a cluster of cells) in the labyrinthine layer showed
that it was reduced by approximately 50% in the PDGFB
2/2 embryo at E13.5 and E16.5 (Figs. 8B–8E). A similar
reduction was seen in PDGFRb 2/2 placentas (data not
shown). The actual loss of ASMA-positive cells in mutant
placentas may be even larger, since in the wild-type,
ASMA-positive cells were frequently found in clusters,
whereas this was less apparent in the mutants (Figs. 8 and
9).
By ASMA and isolectin double labeling, the spatial rela-
tionships between the placenta pericytes and the fetal
vessels could be studied in further detail (Fig. 9). In wild-
type placentas, the pericytes were arranged in core-like
structures, around which the fetal vessels were organized
(Figs. 9A, 9C, and 9E). In the mutant placentas, the peri-
cytes were still located to structures, which appeared to join
individual dilated loops to each other (Fig. 9B). These
attachments were regularly thin and appeared to be in the
process of breaking up (arrows in Figs. 9D and 9F), however,
leading to the displacement of pericytes from multicellular
core aggregates to scattered sites in the walls of the dilated
vessels.
DISCUSSION
It has been suggested that PDGFB controls vasculariza-
tion and the proliferative potential of extravillus tropho-
blasts in the human placenta (Goustin et al., 1985;
Holmgren et al., 1991, 1992, 1993). The role of PDGFB and
PDGFRb in the formation of blood vessels has been sup-
ported by substantial genetic evidence in the mouse
(Leve´en et al., 1994; Soriano, 1994; Lindahl et al., 1997a,
1998; Crosby et al., 1998). Here, we provide genetic evi-
dence that PDGFB and PDGFRb directly or indirectly
egulate the development of pericytes and trophoblasts in
he labyrinthine layer of the mouse placenta. High-level
xpression of the mouse PDGFB gene is associated with
elatively late placental development, coinciding with the
xpansion of the labyrinthine layer. The defects arising in
he mutants are clearly seen at E13.5 (Figs. 5 and 8), which
orrelates in time with the onset of strong PDGFB expres-
ion in the normal placenta. Moreover, the placenta defects
re restricted to the labyrinthine layer, which is the onlyFIG. 3. Morphology of fetal placentas devoid of functional PDGFB
and PDGFRb genes. (A) Electron microscopic image of the labyrin-
thine layer depicting the absence of endothelial cells (en) in the
maternal lacunas (ml) of an E17.5 placenta. Fetal vessel (fv);
labyrinth trophoblast (lt). (B) Matrix between the endothelium of
the fetal vessels and the labyrinth trophoblasts of the maternal
lacunas was stained with isolectin B4. (C and D) Isolectin staining
of a PDGFB 2/2 (D) and a wild-type littermate (C) E17.5 placenta.
(E and F) Isolectin staining of a PDGFRb 2/2 (F) and a wild-type
ittermate (E) placenta. Note that in the wild-type placentas, the
etal and the maternal blood vessels are equal in size and number,
hereas in the mutant placentas, the fetal blood vessels are larger
nd less abundant than the maternal vessels. Scale bars, (A) 0.01
art of the placenta showing PDGFB and PDGFRb expres-
s of reproduction in any form reserved.
(129PDGF and Placental DevelopmentFIG. 4. Overview morphology of placentas stained with PAS–Schiffs reagents and Mayer’s hematoxylin–eosin. For optimal resolution,
24–32 images (each representing a 10-fold magnification) per placenta specimen were integrated using the Adobe PhotoShop program. (A)
Wild-type placenta. (B) PDGFB 2/2 placenta. (C) PDGFRb 2/2 placenta. Age E18.5. Labyrinthine layer (lt) and spongiotrophoblast layer
st) are indicated. Scale bars, 1 mm and in the inserts 0.1 mm.
Copyright © 1999 by Academic Press. All rights of reproduction in any form reserved.
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130 Ohlsson et al.sion. The normal pattern of PDGFB mRNA expression in
he mouse placenta correlates both temporally and spa-
ially, therefore, with the defects in this organ that develop
n PDGFB 2/2 and PDGFRb 2/2 conceptuses. This
strongly suggests that the placenta phenotype results from
deficient local PDGFB/Rb signaling in the developing pla-
centa rather than from systemic effects involving the em-
bryo.
The phenotypic alterations in PDGFB- and PDGFRb-
eficient placentas comprise dilated embryonic blood ves-
els and reduced numbers of pericytes and labyrinth tropho-
lasts. It has been demonstrated in vitro that trophoblasts
nd pericytes may express PDGFRb (Goustin et al., 1985;
olmgren et al., 1992; D’Amore and Smith, 1993; Bernstein
t al., 1982) and these cells may, therefore, be directly
argeted by mitogenic or other actions of PDGFB in the
eveloping placenta. Previous studies of PDGFB- and
DGFRb-null mice have demonstrated pericyte loss in the
eveloping brain (Lindahl et al., 1997a) and mesangial cell
oss in kidney glomeruli (Leve´en et al., 1994; Soriano, 1994).
FIG. 5. PDGFB regulates the development of the labyrinthine lay
(A) E14.5 placenta (PDGFB 1/1). (B) E13.5 placenta (PDGFB 1/1).
13.5 placenta (PDGFB 2/2). (F) E12.5 placenta (PDGFB 2/2). Plac
lthough the control placenta of E12.5 is hemizygous for the PDGF
ne functional PDGFB allele has so far not generated any recogniz
oriano, 1994; and data not shown). Labyrinthine layer (lt) and spo
or all. The scale bar corresponds to 0.2 mm.There are data to suggest that both mitosis and migration of t
Copyright © 1999 by Academic Press. All rightthese cells may be controlled by PDGFB in vivo (Lindahl et
al., 1998; M. Hellstro¨m et al., submitted for publication).
The loss of brain pericytes and kidney mesangial cells
correlates with the formation of increased diameter capil-
lary loops and focal microaneurysms. In both cases, the
pericyte/mesangial cell loss has been suggested to be the
trigger for capillary dilation. Pericytes and mesangial cells
have been shown to express PDGFRb, constituting the
ikely primary target for PDGFB released by capillary endo-
helial cells (Lindahl et al., 1997a, 1998). Any effects arising
n the endothelial cells because of PDGFB disruption are
ikely to be secondary to the pericyte/mesangial cell loss. It
s tempting to speculate that a similar scenario prevails in
he placenta, but the unequivocal establishment of the
DGFB/Rb expression pattern is more difficult in this
rgan than at many other sites, due to the complex histol-
gy of the labyrinthine layer. It also remains to be demon-
trated exactly which cellular mechanism(s) is controlled
y PDGFB signaling in the developing placenta.
Despite these uncertainties, we would like to propose
olectin-stained mouse placenta at different developmental stages.
12.5 placenta (PDGFB 1/2). (D) E14.5 placenta (PDGFB 2/2). (E)
in (A)/(D), (B)/(E), and (C)/(F) are derived from sibling conceptuses.
l allele (no wild-type littermate was available), the presence of only
phenotype in placental or fetal development (Leve´en et al., 1994;
trophoblast layer (st) are indicated. The magnification is the sameer. Is
(C) E
entas
B nul
able
ngiohat the reduction in pericyte density, and perhaps altered
s of reproduction in any form reserved.
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131PDGF and Placental Developmentpericyte function, underlies the labyrinth blood vessel dila-
tion. The position of placenta pericytes between individual
labyrinth capillary loops suggests that the cells are involved
in attachment of the loops to each other (Fig. 9A; schemati-
FIG. 6. Morphometric analyses of mouse fetal placentas. Surfa
aternal blood lacunas were measured from different randomly c
2/2, and PDGFRb 2/2 placentas as outlined under Materials and
mall to be visualized. (A) The frequency distribution of size and nu
arametric length (surface of blood compartment; 1000 units equiv
000 units equivalent to 1 mm2) are represented by blue and red col
f the endothelial and trophoblast tissues facing the fetal and mat
FIG. 7. Cell numbers of labyrinthine layer cell components in mo
B) per counted area (0.27 3 0.21 mm) were estimated as outline
abyrinthine trophoblast layer and the spongiotrophoblast layer. Pl
olumns without error bars show a standard deviation too small to be
Copyright © 1999 by Academic Press. All rightally illustrated in Fig. 10). This appears analogous to how
esangial cells connect the capillary loops in the kidney
lomerulus (Fig. 10). In the kidney, mesangial cells appar-
ntly have an important morphogenetic role in promoting
eas (parametric length) surrounding the fetal blood vessels and
areas in the labyrinth trophoblast layer from wild-type, PDGFB
thods. Columns without error bars show a standard deviation too
rs of maternal and fetal blood vessels in the labyrinthine layer. The
to 1 mm) and parametric surface (volume of blood compartment;
espectively. (B) The ratio of the average surface (parametric length)
blood, respectively.
etal placenta. Numbers of trophoblastic cells (A) and blood vessels
der Materials and Methods. (C) Absolute volumes (mm3) of the
ta age was E17.5. Error bars show standard deviations of the data.ce ar
hosen
Me
mbe
alent
ors, ruse f
d un
acenvisualized.
s of reproduction in any form reserved.
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132 Ohlsson et al.FIG. 8. Pericyte reduction in PDGFB 2/2 placentas. Placental pericytes were visualized by ASMA staining (black). Pericytes were found
n the labyrinthine layer but not in the spongiotrophoblast layer. Micrographs show representative fields from the labyrinthine layer of
12.5, E13.5, or E16.5 placentas (A–F). Note the reduction in pericyte density in the PDGFB 2/2 placentas ages E13.5 and E16.5 in
omparison with the wild-type controls. (G) A comparison of pericyte density between placentas of different ages and genotypes by counting
SMA-stained profiles in equal-sized microscopic fields. Error bars indicate the standard deviation. All micrographs are of the same
agnification. The scale bar in (F) represents 0.1 mm.
Copyright © 1999 by Academic Press. All rights of reproduction in any form reserved.
133PDGF and Placental DevelopmentFIG. 9. Spatial location of pericytes in wild-type and PDGFB 2/2 placentas. ASMA (black) and B4 isolectin (blue) double staining of E16.5
placentas. In the wild-type placenta, the ASMA-positive pericytes locate centrally in small clusters of fetal capillary loops and appear to
hold these loops together (white asterisks in (C) and (E), which show two high-magnification views of the section in (A)). A similar spatial
location of ASMA-positive cells is seen in PDGFB 2/2 placentas, although many ASMA-positive cells appear have detached from each
other and located to the wall of dilated fetal vessels (arrows in (D) and (F)). Scale bars, 0.1 mm.
Copyright © 1999 by Academic Press. All rights of reproduction in any form reserved.
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134 Ohlsson et al.the formation of a complex tuft of capillaries. In PDGFB- or
PDGFRb-deficient kidneys, which lack mesangial cells,
ither a single or a few dilated capillary loops develop
Leve´en et al., 1994; Soriano, 1994; Lindahl et al., 1998).
esangial cells also have an important mechanical func-
ion in preserving the architecture of the mature tuft, since
njury to mesangial cells elicited by Thy-1 antibodies, or
enom toxins, results in the formation of dilated capillary
oops (Bagchus et al., 1986; Uiker and Kriz, 1995). Pericytes
f the placenta labyrinthine layer may have analogous
orphogenetic and structural functions in the development
r maintenance of the complex network of fetal blood
essels. Loss of such pericytes may underlie the labyrinth
etal vessel dilation (Fig. 10).
The reduced number of labyrinth trophoblasts in the
DGFB-deficient placenta is likely to cause the reduction in
FIG. 10. Schematic illustration of analogies between blood vesse
DGFRb deficiency. Capillary loops in the labyrinthine layer are
apillaries organize (A). In mutant placentas (B), the pericytes a
orrelates with (and may be the cause of) vessel dilation. Placental
o that of mesangial cells in kidney glomeruli, which constitute t
esangial cells, as appears in PDGFB- or PDGFRb-mutant glomeru
mesangial cells have similar marker expression and mesangial cells
tufts, the placental pericytes and mesangial cells seem to have crit
nutrient exchange, excretion, and filtration.he surface area of the maternal lacunas in the labyrinthine p
Copyright © 1999 by Academic Press. All rightayer (Fig. 7B). Such trophoblastic lacunas are filled with
aternal blood, which carries nutrients to, and waste
roducts from, the fetus. The 1:1 ratio in the surface areas
etween the trophoblast lacunas and the fetal blood vessels
ould seem to be rational for an efficient nutrient–waste
xchange. According to this reasoning, a reduction in the
urface area of trophoblastic lacunas would lead to a sub-
ptimally functioning placenta, forcing the conceptus to
dopt either of two avenues. One of these would be to adapt
o the reduced supply of nutrients by reducing the growth of
he embryo/fetus. Consistent with this, PDGFB 2/2 em-
ryos are approximately 20% smaller than PDGFB 1/1
mbryos at E14.5 until term (M. Hellstro¨m et al., unpub-
ished). An alternative avenue is that the relative blood
olume of the placenta increases to compensate for the
educed availability of maternal blood. This is also sup-
anization in the placenta and the kidney and effects of PDGFB or
ed by placental pericytes, which form a core around which the
duced in number and detached from the core structures, which
ytes appear, therefore, to have a function that is highly analogous
re around which glomerular capillaries are organized (C). Loss of
ults in glomerular capillary ballooning (D). Placental pericytes and
been suggested to be specialized pericytes. By organizing capillary
oles in establishing complex large-surfaced structures involved inl org
join
re re
peric
he co
li, res
have
ical rorted by the morphometric analysis showing dilated em-
s of reproduction in any form reserved.
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135PDGF and Placental Developmentbryonic blood vessels containing a larger volume of embry-
onic blood. In this context, it is interesting to note that
PDGFB- and PDGFRb-null embryos have macrocytic ane-
ia and thrombocytopenia and an increased proportion of
irculating nucleated erythroblasts at late gestation (Leve´en
t al., 1994; Soriano, 1997). This may in part be accounted
or by hemorrhage due to ruptured microvessels in the
mbryo (Lindahl et al., 1997a), but the present study adds
he possibility that embryonic anemia results from the
ccumulation of a larger volume of fetal blood in the
lacenta. The erythroblastosis may be secondary to the
nemia, reflecting a mechanism of compensation involving
ncreased release of immature blood cells from the hema-
opoietic organs (e.g., liver and spleen).
In summary, we have shown here that absence of
DGFB/Rb signaling perturbs the structure of the nutrient–
waste exchange system of the fetal placenta. Specifically,
PDGFB- and PDGFRb-deficient placentas display abnor-
malities confined to the labyrinthine layer, involving peri-
cyte and trophoblast loss and fetal blood vessel dilation.
The labyrinthine layer normally expresses both PDGFB and
PDGFRb during late development. PDGFB signaling is
herefore likely to act locally to contribute to the formation
f a properly structured labyrinthine layer. Analogous phe-
otypes of PDGFB- or PDGFRb-null placentas and kidney
lomeruli may suggest that the PDGFB/Rb signaling sys-
tem has a generic function in the formation of cells (spe-
cialized pericytes) with critical morphogenetic roles in the
generation of vascular structures involved in both excretion
and nutrient exchange.
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